Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review

by Asger S. Paludan-Müller, Perrine Créquit, Isabelle Boutron
Published 2021-04-01

Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France.

by Kokuvi Atsou, Perrine Crequit, Christos Chouaid, Gilles Hejblum
Published 2016-01-01

Published trials of TACE for HCC are often not registered and subject to outcome reporting bias

by Jules Grégory, Perrine Créquit, Valérie Vilgrain, Isabelle Boutron, Maxime Ronot
Published 2021-02-01

Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systemati...

by Perrine Créquit, Anna Chaimani, Amélie Yavchitz, Nassima Attiche, Jacques Cadranel, Ludovic Trinquart, Philippe Ravaud
Published 2017-10-01

Avoidable waste of research related to outcome planning and reporting in clinical trials

by Youri Yordanov, Agnes Dechartres, Ignacio Atal, Viet-Thi Tran, Isabelle Boutron, Perrine Crequit, Philippe Ravaud
Published 2018-06-01

Accuracy in detecting inadequate research reporting by early career peer reviewers using an online CONSORT-based peer-review tool (COBPeer) versus the usual peer-review process: a...

by Anthony Chauvin, Philippe Ravaud, David Moher, David Schriger, Sally Hopewell, Daniel Shanahan, Sabina Alam, Gabriel Baron, Jean-Philippe Regnaux, Perrine Crequit, Valeria Martinez, Carolina Riveros, Laurence Le Cleach, Alessandro Recchioni, Douglas G. Altman, Isabelle Boutron
Published 2019-11-01